Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alcon Inc.

91.38
-1.1600-1.25%
Post-market: 91.380.00000.00%16:43 EDT
Volume:905.61K
Turnover:82.85M
Market Cap:45.20B
PE:44.58
High:93.17
Open:92.40
Low:90.69
Close:92.54
Loading ...

Investing in Alcidion Group (ASX:ALC) a year ago would have delivered you a 65% gain

Simply Wall St.
·
2 hours ago

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

GlobeNewswire
·
09 Apr

Here’s Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC)

Insider Monkey
·
08 Apr

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Dow Jones
·
08 Apr

When Will Alcidion Group Limited (ASX:ALC) Become Profitable?

Simply Wall St.
·
07 Apr

Alcon Publishes Agenda for 2025 Annual General Meeting

Business Wire
·
04 Apr

ALC Stock May Rise With the Introduction of PanOptix Pro in US

Zacks
·
03 Apr

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

Business Wire
·
02 Apr

UBS Sticks to Their Buy Rating for Alcon (ALC)

TIPRANKS
·
02 Apr

Alcon Is Maintained at Overweight by Keybanc

Dow Jones
·
31 Mar

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar

Oppenheimer Remains a Buy on Alcon (ALC)

TIPRANKS
·
28 Mar

Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?

Zacks
·
28 Mar

Alcon Is Maintained at Buy by Needham

Dow Jones
·
28 Mar

Alcon AG : Mizuho Raises Target Price to $120 From $115

THOMSON REUTERS
·
28 Mar

Needham Raises Price Target on Alcon to $110 From $107, Keeps Buy Rating

MT Newswires Live
·
28 Mar

Alcon Deal for Aurion Follows 2022 Investment, 2024 Lawsuit -- Market Talk

Dow Jones
·
27 Mar

Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment

Dow Jones
·
27 Mar

Alcon Buys Majority Stake in Aurion Biotech

MT Newswires Live
·
27 Mar

Press Release: Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Dow Jones
·
27 Mar